NYSE · traded in Congress
Thermo Fisher Scientific TMO
$700.02 +5.26 (+0.76%) Nov 9, 2026 4:30 AM ET
Market value$259.4B
P/E ratio-
Analyst target$750.00
52-week range-
Avg volume1,324,848
Dividend yield-
Chart
Analyst ratings
- 24 buy
- 4 hold
- 1 sell
Low target$675.00
Average target$766.12
High target$830.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $12,137M | - | $1,721M | 14.2% | |
| $11,994M | - | $1,736M | 14.5% | |
| $11,005M | - | $1,651M | 15.0% | |
| $12,215M | - | $1,964M | 16.1% |
Congress trades in TMO
Members of Congress disclosed 2 transactions in TMO in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 07/10/2026 | Dan Newhouse WA04 | Sale | $1,001 - $15,000 | 7/17/2026 filing |
| 05/07/2026 | Dwight Evans PA03 | Partial sale | $1,001 - $15,000 | 5/15/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
